ICD-10-CM Billable Code

QA0.0102

CACNA1A-related neurodevelopmental disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

CACNA1A-related neurodevelopmental disorder is a genetic condition affecting the brain and nervous system. It results from mutations in the CACNA1A gene, which plays a crucial role in calcium channel functioning within nerve cells. This disorder can lead to a range of neurological symptoms, developmental delays, and movement problems. Recognizing its features and understanding its underlying causes can help in managing the condition effectively.

Causes & Symptoms

Clinical Causes: Mutations in the CACNA1A gene that disrupt normal calcium channel formation Inheritance of faulty gene variants from one or both parents (familial cases) De novo mutations, which occur spontaneously without being inherited Environmental factors are not known to directly cause this disorder Variations in genetic expression that influence severity and specific symptoms

Key Symptoms: Developmental delays, including slower learning and speech difficulties Intellectual disability in some individuals Migraine headaches, often described as intense and recurrent Problems with coordination and balance, leading to gait abnormalities Muscle weakness or hypotonia (low muscle tone) Seizures, which may vary in type and severity Ataxia, resulting in unsteady movements Dysarthria, affecting speech clarity Eye movement abnormalities, such as nystagmus or strabismus Behavioral issues, including hyperactivity or social challenges

Diagnostic & Treatment

Diagnosis Path: Diagnosing CACNA1A-related neurodevelopmental disorder involves a comprehensive evaluation that includes clinical assessment, neurological examination, and detailed developmental history. Genetic testing plays a crucial role in confirming the diagnosis by identifying mutations in the CACNA1A gene. Brain imaging techniques, like MRI, may be used to observe structural brain differences. Differential diagnosis is important to rule out other neurodevelopmental disorders with overlapping symptoms.

Treatment Protocols: There is currently no cure for CACNA1A-related neurodevelopmental disorder. Treatment aims to manage symptoms and support development. This includes a multidisciplinary approach involving neurologists, geneticists, speech and occupational therapists, and psychologists. Medications may be prescribed to reduce seizure frequency or alleviate migraine symptoms. Physical and speech therapy can help improve motor skills and communication. Educational support and behavioral interventions are tailored to individual needs to enhance learning and social skills. Ongoing medical monitoring is essential to address evolving symptoms and complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is QA0.0102 a billable ICD-10 code?
Yes, QA0.0102 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report QA0.0102?
Clinical documentation must specify the nature of CACNA1A-related neurodevelopmental disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference